Lorraine Boakye, MD
Orthopaedic Surgery · Philadelphia, PANPI 1205286416
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (49.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 75.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $15,962 and has fallen 92.3% since, to $1,229 in 2025.
Across 71 payments — averaging $283.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$15K
- Smith+Nephew$1K
- Stryker$1K
- Kairos Surgical Inc$1K
- Paragon 28, Inc.$467
- Novastep Inc.$325
- plus $530 from 6 others
Across 5 payments — averaging $2856.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Treace Medical Concepts, Inc.$14K
What the payments were for
- Grants$10,00050%
- Travel & lodging$1,1706%
- Food & beverage$4,16921%
- Education$4,80024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $15,119 |
| Smith+Nephew | 16 | $1,256 |
| Stryker | 13 | $1,228 |
| Kairos Surgical Inc | 2 | $1,213 |
| Paragon 28, Inc. | 5 | $467 |
| Novastep Inc. | 3 | $325 |
| Liberty Surgical Inc. | 2 | $177 |
| Johnson & Johnson | 1 | $130 |
| Trilliant Surgical LLC. | 1 | $109 |
| Terumo BCT, Inc. | 1 | $56 |
| Paladin Technology Solutions | 2 | $34 |
| Integra Lifesciences Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Panta 2$413
- BIOFOAM$277
- Oasis$267
- Stravix$267
- GRAFIX PL$249
- STRAVIX PL$249
- OASIS MICRO$249
- Grafix$154
- PECA Bunion Correction System$145
- STAR$133
- VA-LCP$130
- INFINITY$120
- TRAUMA$115
- Minimally Invasive Bunion Plate, Left$109
- ORTHOLOC 3DI CROSSCHECK$105
- Ankle Fracture$105
- ANCHORAGE$104
- NEXIS$102
How this compares
$20,139 in reported general payments places this provider in the 80th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 12 | $166 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Philadelphia
- John FenlinPhiladelphia$5.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Samir MehtaPhiladelphia$3.6M
- Surena NamdariPhiladelphia$1.8M
- Neil ShethPhiladelphia$522K
- Amrit KhalsaPhiladelphia$475K
- Vahid EntezariPhiladelphia$393K
- Charles NelsonPhiladelphia$345K
- David GlaserPhiladelphia$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.